Investment
Features
FeesSafety
Academy
More
Pluang+

Mama's Creations posts 55% revenue growth, eyes big acquisition with $138.6M cash reserve

Analyst Insights
06 Sep 2026
Seeking Alpha
View Source
Neutral
Mama's Creations posts 55% revenue growth, eyes big acquisition with $138.6M cash reserve

Mama's Creations reported a strong quarter with revenue up 55% and EBITDA up 70%, driven by solid organic growth and successful integration of Crown. The company holds $138.6 million in cash, positioning it well for a significant acquisition to help reach its $1 billion revenue goal. However, sequential revenue growth has stalled and the stock's valuation remains high with a forward P/E of 67x, leading to a Hold rating. The next acquisition is seen as a crucial test for value creation before considering a Buy upgrade.

More News

Vistra CEO buys 2,000 shares after stock drops 29%, signaling confidence in recovery.

Vistra CEO buys 2,000 shares after stock drops 29%, signaling confidence in recovery.

Vistra's CEO, James Burke, purchased 2,000 shares following a significant 29% decline in the company's stock price. This insider buying suggests confidence in the company's future prospects despite recent losses. Investors may view this move as a pos...

Market News
Bullish
1 hour ago
Deadline set for $STPT to $AWE token swap on Sept 21, 2026, with over 99% already migrated

Deadline set for $STPT to $AWE token swap on Sept 21, 2026, with over 99% already migrated

Awen Network has set September 21, 2026, as the final deadline for holders to migrate their legacy $STPT tokens to the new $AWE tokens. Over 99% of the total 1.94 billion tokens have already been swapped at a 1:1 ratio since the migration began in Ma...

Protocol Fundamentals
Neutral
4 hours ago
Allogene Therapeutics undervalued with promising ALPHA3 therapy and strong cash runway to 2029

Allogene Therapeutics undervalued with promising ALPHA3 therapy and strong cash runway to 2029

Allogene Therapeutics is seen as undervalued by the market despite promising clinical progress with its ALPHA3 therapy, which targets MRD-guided first-line consolidation with strong early MRD clearance and a clean outpatient profile. The company hold...

Analyst Insights
Bullish
4 hours ago
Goldman Sachs Equal Weight U.S. Large Cap ETF outperforms SPY with low fees and monthly rebalancing.

Goldman Sachs Equal Weight U.S. Large Cap ETF outperforms SPY with low fees and monthly rebalancing.

The Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) offers diversified exposure to large U.S. companies with an equal-weight strategy and monthly rebalancing. It has outperformed the SPY year-to-date by reducing concentration in mega-cap ...

Analyst Insights
Bullish
4 hours ago
Atlas Copco poised for growth with 26% order rise amid booming semiconductor demand

Atlas Copco poised for growth with 26% order rise amid booming semiconductor demand

Atlas Copco is benefiting from strong demand in the semiconductor industry, especially through its Vacuum Technique and compressor segments. The company reported a 26% organic increase in orders and a 21% operating margin, with Vacuum Technique order...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App